AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar pchop123 (71.80) Submitted: 1/30/2012 12:18:06 PM : Underperform Start Price: $2.91 AVNR Score: +5.68

the numbers do not work for me

Featured Broker Partners


Advertisement